Relationship between plasma oxipurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol.
- 1 October 1988
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 26 (4), 429-434
- https://doi.org/10.1111/j.1365-2125.1988.tb03402.x
Abstract
1. 1‐methyl xanthine (1‐MX) is metabolized exclusively to 1‐methyl uric acid (1‐MU) by the enzyme xanthine oxidase. 2. The ratio of 1‐MU to 1‐ MX in the urine, following a dose of 50 mg of 1‐MX infused intravenously over 20 min, was used to measure the inhibition of xanthine oxidase induced by different doses of allopurinol. 3. Normal volunteers (n = 8) were given allopurinol 50, 100, 300 and 600 mg daily for 1 week each, in random order and 1 week separated each treatment. Inhibition of xanthine oxidase was assessed twice, on the last 2 days of each treatment week. 4. Steady‐state oxipurinol concentrations increased linearly with increasing dose of allopurinol. 5. There was a hyperbolic relationship between the 1‐MU/1‐MX ratio and plasma oxipurinol concentrations, with an initial steep decline in the ratio which plateaued when plasma oxipurinol was around 4‐6 mg l‐1. This reduction in the ratio was quickly reversible upon cessation of allopurinol. 6. The 50% and 90% effective inhibitory oxipurinol concentrations, in relation to the 1‐MU‐/1‐MX ratio were 1.4 +/‐ 0.46 and 4.08 +/‐ 2.03 mg l‐1 respectively. 7. The concentration of oxipurinol required for almost complete inhibition of the enzyme was substantially less than those often observed in clinical practice.This publication has 24 references indexed in Scilit:
- PLASMA OXIPURINOL CONCENTRATIONS DURING ALLOPURINOL THERAPYRheumatology, 1987
- Severe allopurinol toxicityThe American Journal of Medicine, 1984
- Understanding the Dose-Effect RelationshipClinical Pharmacokinetics, 1981
- High-performance liquid chromatographic assay for allopurinol and oxipurinol in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1979
- Allopurinol and Other Inhibitors of Urate SynthesisPublished by Springer Nature ,1978
- Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFITJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Inhibition of urate production by allopurinolBiochemical Pharmacology, 1977
- Urinary excretion of purines, pyrimidines and pyrazolopyrimidines in patients treated with allopurinol or oxipurinolClinica Chimica Acta; International Journal of Clinical Chemistry, 1969
- Metabolic studies of allopurinol, an inhibitor of xanthine oxidaseBiochemical Pharmacology, 1966
- Clinical, physiological and biochemical studies of a patient with xanthinuria and pheochromocytomaThe American Journal of Medicine, 1964